Loading clinical trials...

Growth and Tolerance of Healthy Term Infants to a New Infant Formula | Clinical Trials | Clareo Health

TERMINATEDPhase 3NCT01137877

Growth and Tolerance of Healthy Term Infants to a New Infant Formula

The objective of this study is to evaluate the effect of two experimental milk-based infant formulas on the growth and gastrointestinal (GI) tolerance of term infants.

Lead sponsor: Abbott Nutrition•20 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDNA

Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life

NCT02646969 · Healthy Term Infants

COMPLETEDNA

Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.

NCT04015050 · Healthy Term Infants

COMPLETEDNA

Growth and Safety of a Low Lactose Milk-Based Infant Formula

NCT01497314 · Growth, Healthy Term Infants

COMPLETEDPhase 3

Tolerance of Healthy Term Infants Fed Infant Formulas #4

NCT01155414 · Healthy Term Infants

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 25, 2010Terms

Trial snapshot

StatusTERMINATED

PhasePHASE3

Enrollment399

Start dateMay 2010

Last updatedNov 25, 2010

Condition

Healthy Term Infants

Locations shown

Arkansas Children's Hospital Research

Little Rock, Arkansas

Facey Medical Foundation

Mission Hills, California

Norwich Pediatric Group

Norwich, Connecticut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 25, 2010Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Growth and Tolerance of Healthy Term Infants to a New Infant Formula

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life

Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.

Growth and Safety of a Low Lactose Milk-Based Infant Formula

Tolerance of Healthy Term Infants Fed Infant Formulas #4

Trial snapshot

Condition

Locations shown

For caregivers